Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. Aug 24, 2022; 13(8): 688-701
Published online Aug 24, 2022. doi: 10.5306/wjco.v13.i8.688
Figure 4
Figure 4 Kaplan-Meier curves representing. A: post-liver transplant overall survival; B: recurrence-free survival in patients with mixed hepatocellular-cholangiocarcinoma compared with patients with hepatocellular carcinoma (HCC), matched 1:8 for pretransplant tumor characteristics; C: post-liver transplant overall survival; D: recurrence-free survival in patients with mixed hepatocellular-cholangiocarcinoma compared with patients with hepatocellular carcinoma matched 1:8 for posttransplant tumor characteristics. HCC: hepatocellular carcinoma; HCC-CC: hepatocellular-cholangiocarcinoma; HRs: Hazard ratios; CIs: Confidence intervals.